Cue Biopharma, Inc. (CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases Transcript By Sigma Griffin · April 7, 2026 · 1 min read cuesa transcripts Source: seekingalpha.com